Payables, accruals and other current liabilities |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||
| Payables, accruals and other current liabilities | |||||||||||||||||||||||||||||||||||||||||
| Payables, accruals and other current liabilities | 12. Payables, accruals and other current liabilities
All payables mature within 3 months. Accrued expenses and trade payables primarily relate to R&D services from contract research organizations, consultants and professional fees. The total amount of payables, accruals and other current liabilities increased by CHF 0.1 million as of June 30, 2026 compared to December 31, 2025, primarily due to increased trade payables. The carrying amounts of payables do not materially differ from their fair values, due to their short-term nature. |